Herlitz J, Hjalmarson A, Waldenström J, Swedberg K, Waagstein F, Waldenström A
Br Heart J. 1983 Dec;50(6):520-4. doi: 10.1136/hrt.50.6.520.
In 585 patients with a first acute myocardial infarction the maximum activity of heat stable lactate dehydrogenase (EC 1.1.1.27) was correlated with mortality at three months. The patients participated in a double blind trial with metoprolol in acute myocardial infarction. In all patients not taking a beta blocker a highly significant correlation was found, but this was not evident in those who were. When patients with anterior or inferior infarctions treated with a placebo were analysed separately the correlation remained, as it did when the patients who were alive on the fourth day after the onset of pain were analysed separately. No correlation was observed between enzyme activity and three month mortality in these subgroups if only patients treated with metoprolol were included. In a subsample of only 171 patients it was found that the maximum activity of creatine kinase (EC 2.7.3.2) and creatine kinase subunit B did not correlate with three month mortality regardless of treatment. Thus it is concluded that when a sufficiently large number of patients are investigated there is a highly significant correlation between the enzymatic estimation of infarct size and early mortality in acute myocardial infarction. This relation did not persist when patients treated with beta blockade were analysed.
在585例首次发生急性心肌梗死的患者中,热稳定乳酸脱氢酶(EC 1.1.1.27)的最大活性与三个月时的死亡率相关。这些患者参与了一项急性心肌梗死中使用美托洛尔的双盲试验。在所有未服用β受体阻滞剂的患者中发现了高度显著的相关性,但在服用者中并不明显。当分别分析接受安慰剂治疗的前壁或下壁梗死患者时,相关性依然存在,对疼痛发作后第四天仍存活的患者分别分析时也是如此。如果仅纳入接受美托洛尔治疗的患者,在这些亚组中未观察到酶活性与三个月死亡率之间的相关性。在仅171例患者的子样本中发现,无论治疗情况如何,肌酸激酶(EC 2.7.3.2)和肌酸激酶亚基B的最大活性与三个月死亡率均无相关性。因此得出结论,当对足够多的患者进行研究时,急性心肌梗死中梗死面积的酶学评估与早期死亡率之间存在高度显著的相关性。在分析接受β受体阻滞剂治疗的患者时,这种关系并不持续存在。